Gilboa Therapeutics is a game-changing immunotherapy firm seeking to transform cancer care with SolidT cell therapy.
Employees: 1-10
Founded date: 2020
Investors 1
Mentions in press and media 1
| Date | Title | Description |
| 06.01.2022 | Gilboa Therapeutics to Present at the H.C. Wainwright BioConnect 2022 Conference | SAN DIEGO (PRWEB) January 06, 2022 Gilboa Therapeutics Inc., a preclinical-stage biopharmaceutical company focused on the discovery and development of next-generation cell therapies, today announced that’s its Chief Executive Officer, David... |